company background image
PBH logo

Prestige Consumer Healthcare NYSE:PBH Stock Report

Last Price

US$72.63

Market Cap

US$3.6b

7D

-1.0%

1Y

18.1%

Updated

27 Mar, 2024

Data

Company Financials +

PBH Stock Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally.

PBH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Prestige Consumer Healthcare Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Prestige Consumer Healthcare
Historical stock prices
Current Share PriceUS$72.63
52 Week HighUS$75.31
52 Week LowUS$52.90
Beta0.52
1 Month Change3.79%
3 Month Change17.49%
1 Year Change18.12%
3 Year Change64.77%
5 Year Change157.55%
Change since IPO309.18%

Recent News & Updates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Recent updates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Jun 14
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 50% Below Their Intrinsic Value Estimate

Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call Presentation

May 08

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Apr 19
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?

Feb 22
How Much Did Prestige Consumer Healthcare's (NYSE:PBH) CEO Pocket Last Year?

Shareholder Returns

PBHUS PharmaceuticalsUS Market
7D-1.0%1.2%0.4%
1Y18.1%25.8%28.8%

Return vs Industry: PBH underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: PBH underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is PBH's price volatile compared to industry and market?
PBH volatility
PBH Average Weekly Movement3.8%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PBH has not had significant price volatility in the past 3 months.

Volatility Over Time: PBH's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEO
1996560Ron Lombardi
Website
https://www.prestigebrands.com

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief.

Prestige Consumer Healthcare Inc. Fundamentals Summary

How do Prestige Consumer Healthcare's earnings and revenue compare to its market cap?
PBH fundamental statistics
Market capUS$3.61b
Earnings (TTM)-US$80.67m
Revenue (TTM)US$1.13b

3.2x

P/S Ratio

-44.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PBH income statement (TTM)
RevenueUS$1.13b
Cost of RevenueUS$500.02m
Gross ProfitUS$634.21m
Other ExpensesUS$714.88m
Earnings-US$80.67m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.62
Gross Margin55.92%
Net Profit Margin-7.11%
Debt/Equity Ratio74.9%

How did PBH perform over the long term?

See historical performance and comparison